Finding the right dose of remimazolam for AVF surgery
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests the right dose of a mild sedative called remimazolam for people having surgery to create an arteriovenous fistula (a special blood vessel connection for dialysis). The goal is to make sedation safer and more comfortable during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are scheduled for elective surgery to create an arteriovenous fistula (a connection between an artery and a vein) under local anesthesia.
- You have a body mass index (BMI) between 18 and 28.
- You do not have severe heart, lung, liver, or nerve problems, and you are not allergic to remimazolam or similar medicines.
- You are not taking sedatives or anticonvulsants, and you can cooperate with follow-up after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial compares two ways of giving the sedative remimazolam during brain bypass surgery. It looks at which method uses less medicine. If you are having this surgery, you may be able to join.
This trial tests a sedative called remimazolam for women undergoing gynecological surgeries like hysterectomy or fibroid removal. The goal is to see how it works and if it's a good option for anesthesia.
Hear when a new Uremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.